Literature DB >> 32617059

Are Symptoms Sufficient in the Decision to Start Antibiotics in Tonsillopharyngitis?

Elif Serap Esen1, Memet Taskin Egici1, Guzin Zeren Ozturk1.   

Abstract

OBJECTIVES: Unnecessary use of antibiotics is one of the causes of antibiotic resistance. Rapid Antigen Test (RAT) is recommended to prevent unnecessary use of antibiotics by providing bacteria/virus isolation in patients with tonsillopharyngitis. However, in patients with typical symptoms, false-negative test results may lead to doubt in doctors. In this study, we aimed to evaluate the relationship between patients' symptoms and RAT results.
METHODS: In this study, we chose the patients that referred to the University of Health Sciences (SBÜ) Şişli Hamidiye Etfal Training and Research Hospital Family Medicine Polyclinics and got a diagnosis of tonsillopharyngitis with RAT. This study was conducted by a retrospective file scanning method. We examined the age, sex, symptoms, RAT results and throat culture results of the patients. SPSS 15.0 for Windows program was used for the statistical analysis. The level of statistical significance was accepted as p<0.05.
RESULTS: In this study, the RAT of 265 patients and the throat culture of 141 patients were examined. We found RAT positivity as 28.7%, Group A Beta Hemolytic Streptococcus (AGBHS) detection rate in throat culture was 22.5%, and the antibiotic prescription rate was 37%. There were 32 patients with AGBHS positivity in throat culture. Twenty-seven of them got RAT positivity, too. When symptoms and RAT positivity were examined, there was no significant relationship between RAT positivity and fever higher than 38 oC, but RAT was more often positive in patients with a fever higher than 38 oC. On the other hand, there is a statistically significant relationship between RAT positivity and the presence of tonsillar exudate (p=0.000). When the relationship between symptoms and RAT according to age groups was examined, the presence of LAP and tonsillitis were significant (p=0.000; p=0.001). In the age group of 18 years and over, the presence of tonsillar exudates was significant (p=0.001).
CONCLUSION: In our study, tonsillar exudate was a common symptom in both age groups of <18, and ≥18 years of age; at the same time, there is a statistically significant relation with RAT. Tonsillar exudates are not seen only in bacterial infections but also in viral infections. Thus, we think that antibiotics should not be started based on symptoms, and RAT should be used effectively. Copyright:
© 2020 by The Medical Bulletin of Sisli Etfal Hospital.

Entities:  

Keywords:  Antigens; diagnosis; pharyngitis; streptococcal infections; tonsillitis

Year:  2020        PMID: 32617059      PMCID: PMC7326667          DOI: 10.14744/SEMB.2018.01336

Source DB:  PubMed          Journal:  Sisli Etfal Hastan Tip Bul        ISSN: 1302-7123


Tonsillopharyngitis is an acute inflammation of the pharynx, tonsilla palatina, or both. Among its symptoms, sore throat, difficulty in swallowing, cervical lymphadenopathy and fever are included.[1] The diagnosis is made through clinical findings, throat culture and rapid antigen test (RAT). The most important reasons for applying to primary health care institutions are upper respiratory tract infections (URTsI), including acute tonsillopharyngitis. Many bacterial and viral agents are the causes of tonsillopharyngitis, but the most common pathogenic agents are viruses. The most important cause of bacterial tonsillopharyngitis is Group A Beta Hemolytic Streptococci (GABHS), which is responsible for approximately 15-20% of all cases of tonsillopharyngitis.[2, 3] According to the Turkish Statistical Institute data concerning the year 2016, upper respiratory tract infections account for 42.6% of major childhood diseases experienced by children aged 0-6 years within the previous six months.[4] According to a study conducted in Turkey, 11.86% of prescriptions are written by family physicians because of the diagnosis of the acute tonsillopharyngitis, 79.58% of the prescription antibiotics are written for acute tonsilopharyngitis.[5] The reason why GABHS tonsillopharyngitis is so important is that it may lead to the development of complications, such as acute rheumatic fever (ARA), peritonsillar abscess, and poststreptococcal glomerulonephritis. The worldwide prevalence of ARA ranges between 9.5-18/100000 and 80-508/100000.[6] Given that ARA can be prevented with the correct treatment is one of the reasons why many physicians prefer antibiotics in tonsillopharyngitis. However, today’s increase in antibiotic resistance has led to the need to limit the use of antibiotics. The important distinction here is the cause of tonsillopharyngitis. RAT is a rapid practical test used in discrimination between virus, and bacteria and restricts the use of unnecessary antibiotics.[7] Unnecessary use of antibiotics is an important cause of antibiotic resistance. Antibiotic resistance is a problem affecting the whole world today. According to the Centers for Disease Control (CDC), in the USA, 2 million people are infected with antibioti-resistant bacteria every year and 23,000 of them die.[8] World Health Organization has strategies to combat antibiotic resistance, which is also implemented in our country. As of January 15, 2017, the implementation of RAT has been started in primary health care institutions. In this application, the patient who comes with a complaint of sore throat is evaluated according to the Centor criteria, and then RAT is started to be performed for the patient who scores 2 or more according to the result of the Centor scoring system. Use of RAT is recommended by the Infectious Diseases Society of America and although it has high sensitivity and specificity;[9] it brings on concerns about delaying antibiotherapy among physicians due to its false-negative results; therefore, in patients with typical symptoms, antibiotics can be started even if the RAT result is negative. In our study, we aimed to evaluate the relationship between RAT results and symptoms.

Methods

This study was performed with the approval of the Istanbul Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences Clinical Research Ethics Committee (07.03. 2018; number, 2037). Since tonsillopharyngitis was most frequently seen during autumn and winter months (10), the patients applied to Family Medicine Policlinics of Istanbul Sisli Hamidiye Etfal Training and Research Hospital between 09.01. 2017 and 03.30.2018 with the diagnosis of tonsillopharyngitis for whom RAT was requested was included in our study. In our clinic, the symptoms of the patients with a sore throat were entered into the hospital information processing system to be evaluated according to the Centor criteria.

Centor Criteria

Centor criteria are used as a clinical scoring method used for differentiation between viral and bacterial tonsillopharyngitis. Scoring is performed based on Centor criteria, which include the presence of fever over 38 oC, lack of cough, presence of tonsillar hypertrophy and/or exudate, sensitive cervical lymphadenopathy (LAP).[11] Each point increase in score increases the risk of streptococcal infection. The risk of contracting streptococcal infection is 1-2% at zero, 5-10% at one,11-17% at two, 28-35% at 3, and 51-53% at ≥4 points.[3] According to the results of the Centor scoring system, RAT is applied to the patient who scores ≥2 points.

RAT/Throat culture

After the tongue is pressed down with a tongue depressor, the swab is applied to both tonsils, posterior pharynx and inflamed areas (if any) to obtain samples that are sent to the laboratory for incubation in culture media or rapid antigen test. In our study, the data of these patients were scanned using the retrospective file scanning method, and age, gender, symptoms of patients, and RAT and culture results were recorded.

Statistical Analysis

SPSS 15.0 for Windows program was used for statistical analysis. Descriptive statistics were given as numbers and percentages for categorical variables. In independent groups, rates were analyzed using chi- square test. When parametric test conditions could not be met in multi-eyed tables, Monte Carlo simulation was applied. Dependent group analyzes were performed using the McNemar test. The statistical alpha significance level was accepted as p<0.05.

Results

Between above-mentioned specified dates, a total of 20.671 patients applied to our outpatient clinic, and 772 of them were diagnosed with tonsillopharyngitis. RAT and throat cultures were requested from 265, and 141 patients, respectively (Fig. 1). In our study, data of 265 patients for whom RAT were requested were analyzed and included in this study (Table 1). The mean age of the patients was 22.77±14.22 years, and 102 (38.5%) cases aged between 3-18 years. Hundred and forty patients (52.8%) were male and any relationship was not found between age and gender (p>0.05).
Figure 1

Data obtained.

Table 1

Demographic, clinical, and laboratory data of the patients included in this study

n%
Age
 <18 years10238.5
 ≥18 years16361.5
Gender
 Female12547.2
 Male14052.8
Symptoms
 Fever >38 ºC14354
 Tonsillar exudate16863.4
 LAP8632.5
 Lack of cough15658.6
Rapid antigen test
 Negative18971.3
 Positive7628.7
Throat culture
 No12446.8
 Yes14153.2
Throat culture
 Normal10977.3
 Group A Beta Hemolytic3222.7
 Streptococci
Treatment
 Untreated238.7
 Symptomatic treatment14454.3
 Antibiotherapy9837
Data obtained. Demographic, clinical, and laboratory data of the patients included in this study A total of 772 patients diagnosed with tonsillopharyngitis between the relevant dates constituted 3.73% of all our patients. RAT positivity was found in 28.7% of the patients, and GABHS was isolated in throat cultures of 22.5% of the patients. Despite this, antibiotherapy was prescribed for 37% of the patients. The least common symptom was LAP positivity. When examined concerning symptoms, fever and tonsillar exudate were statistically significantly more often seen in the group under age 18 when compared with a group of patients aged 18 and older (p=0.000; p=0.000) (Fig. 2).
Figure 2

Comparisons between symptoms, and RAT results in patients aged <18, and ≥18 years.

Comparisons between symptoms, and RAT results in patients aged <18, and ≥18 years. RAT positivity was seen in 38.1% (n=37) and 23.2% (n=39) of the patients in the groups of patients aged <18, and ≥18 years, respectively with a statistically significant intergroup difference (p=0.010). As the age of the patients increases, the number of cases with negative RAT results increases significantly (p=0.043). Although RAT positivity rates were higher in women relative to men, there was no significant relationship between gender and RAT positivity. When the symptoms and RAT positivity were examined one by one, no significant relationship was found between the presence of fever over 38 oC and RAT positivity, and there was a relationship with other symptoms. As seen in Table 2, there is a significant relationship between the presence of tonsillar exudate and RAT positivity (p=0.000).
Table 2

Relationship between symptoms, results of rapid antigen test, and cultures

Rapid Antigen Test PositiveRapid Antigen Test Negativep


n%n%
Tonsillar exudate
 Yes6686.8102540.000
 No1013.28746
LAP
 Yes3242.15428.60.033
 No4457.913571.4
Cough
 Yes2228.987460.011
 No5471.110254
Fever >38 º C
 Yes4863.29550.30.057
 No2836.89449.7
Relationship between symptoms, results of rapid antigen test, and cultures When the symptoms and throat cultures were compared, any relationship between the presence of fever and throat culture was not detected. In culture- negative cases, cough and LAP were more frequently seen (p=0.029; 0.046). Tonsillar exudate was significantly more often observed in throat culture- positive cases (p=0.003). However, when the relationship between symptoms and RAT results was divided into two age groups, there was a significant relationship between RAT positivity and the presence of LAP and the presence of tonsillar exudate in the group under 18 years of age (p=0.000; p=0.001). A significant relationship was found between RAT positivity and tonsillar exudate in patients aged 18 and over (p=0.001).

Discussion

Tonsillopharyngitis is one of the most common diseases in primary care. Tonsillopharyngitis is a disorder that affects mostly the pediatric age group. It is most frequently seen between the ages of 5-15.[12] The mean age of the patients in our study was 22.77±14.22 years, which is because family medicine physicians serve all age groups. In a study in which throat cultures were examined, GABHS infections were found to be higher in men.[13] In our study, there was no significant relationship between gender, and RAT, and throat culture positivity. In our study, we found that RAT positivity was significantly higher under the age of 18 and that RAT positivity decreased with increasing age. Because viruses are pathogenic agents in 90% of the cases with tonsillopharyngitis in adults, but only in 60-75% of pediatric cases.[14] While the detection rate of GABHS in the literature ranges between 5-10% in adults, it was 22.7% in our study.[15] The antibiotic prescription rate was 37%, which is similar to the 2013 surveillance report.[4] In one study, 21% of the patients with positive cultures were untreated, while 47% of the patients with negative cultures were administered treatment.[16] In our study, 25% (n=8) of the patients with positive cultures were not treated; Antibiotics were administered to 12.8% of the patients with negative culture results. One of the reasons for these treatments incompatible with the laboratory results may be that physicians start treatment according to the patient’s clinic without waiting for the results of the culture. In one study, 56% of the cases with streptococcal pharyngitis sore throat, fever, LAP and tonsillar exudate were detected.[17] Studies comparing symptoms with RAT and culture results have been performed. For instance, Steinhoff et al. found a significant relationship between the patients with positive throat cultures and tonsilar exudate, fever over 38 oC, and palpable lymph glands.[18] Nandi et al.[19] detected a relationship between tonsillar growth, hyperemia, and palpable lymph node. Similarly, in our study, the presence of LAP and tonsillar exudate were found to be significant in RAT- positive cases under the age of 18. However, the presence of tonsillar exudate was found significant as for RAT positivity in cases aged ≥18 years. In our study, the detection of tonsillar exudate on physical examination in our study with both adults and children is a common symptom for RAT positivity. Although it was concluded in their study that “tonsillar hypertrophy should seriously suggest the initiation of empirical antibiotherapy”,[20] according to another study, the sensitivity and specificity of antibiotherapy were reported to range 55-74% and 58-76%, respectively.[19] Therefore, we think that the initiation of antibiotherapy should not be decided based on symptomatology alone.

Conclusion

As a common symptom, tonsillar exudate was found to be statistically related to RAT positivity in groups of patients aged <18, and ≥18 years. On the other hand, since tonsillar exudate occurs not only in bacterial infections but also in viral infections, we think that antibiotherapy should not be started based on symptoms alone. In our study, there was a strong harmony between RAT and throat culture. The use of RAT is recommended to reduce unnecessary use of antibiotics by distinguishing bacterial viruses in all applications, especially in family medicine polyclinics.
  10 in total

1.  Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children.

Authors:  M C Steinhoff; M K Abd el Khalek; N Khallaf; H S Hamza; A el Ayadi; A Orabi; H Fouad; M Kamel
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

2.  Principles of appropriate antibiotic use for acute pharyngitis in adults: background.

Authors:  R J Cooper; J R Hoffman; J G Bartlett; R E Besser; R Gonzales; J M Hickner; M A Sande
Journal:  Ann Intern Med       Date:  2001-03-20       Impact factor: 25.391

3.  [Short communication: clinical predictors of group A beta hemolytic streptococci isolation in upper respiratory tract infections].

Authors:  Semiha Solak; Onder Ergönül
Journal:  Mikrobiyol Bul       Date:  2005-07       Impact factor: 0.622

Review 4.  Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children.

Authors:  Elena Chiappini; Marta Regoli; Francesca Bonsignori; Sara Sollai; Alessandra Parretti; Luisa Galli; Maurizio de Martino
Journal:  Clin Ther       Date:  2011-01       Impact factor: 3.393

5.  [Comparative analysis of clinical and laboratory methods for diagnosing streptococcal sore throat].

Authors:  Ana Gabriela P dos Santos; Eitan N Berezin
Journal:  J Pediatr (Rio J)       Date:  2005 Jan-Feb       Impact factor: 2.197

6.  Evaluation of a rapid antigen detection test in the diagnosis of streptococcal pharyngitis in children and its impact on antibiotic prescription.

Authors:  Helen C Maltezou; Vasilios Tsagris; Anastasia Antoniadou; Labrini Galani; Constantinos Douros; Ioannis Katsarolis; Antonios Maragos; Vasilios Raftopoulos; Panagiota Biskini; Kyriaki Kanellakopoulou; Andreas Fretzayas; Theodoros Papadimitriou; Polyxeni Nicolaidou; Helen Giamarellou
Journal:  J Antimicrob Chemother       Date:  2008-09-11       Impact factor: 5.790

7.  Clinical score card for diagnosis of group A streptococcal sore throat.

Authors:  Sobhan Nandi; Rajesh Kumar; Pallab Ray; Harpreet Vohra; Nirmal K Ganguly
Journal:  Indian J Pediatr       Date:  2002-06       Impact factor: 1.967

Review 8.  Pharyngitis.

Authors:  Miriam T Vincent; Nadhia Celestin; Aneela N Hussain
Journal:  Am Fam Physician       Date:  2004-03-15       Impact factor: 3.292

9.  The diagnosis of strep throat in adults in the emergency room.

Authors:  R M Centor; J M Witherspoon; H P Dalton; C E Brody; K Link
Journal:  Med Decis Making       Date:  1981       Impact factor: 2.583

10.  Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.

Authors:  Stanford T Shulman; Alan L Bisno; Herbert W Clegg; Michael A Gerber; Edward L Kaplan; Grace Lee; Judith M Martin; Chris Van Beneden
Journal:  Clin Infect Dis       Date:  2012-09-09       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.